I'd at least like to respond to your first comment about fake pharmaceuticals, just to make sure my comments are clear.
I first noted that I felt health and safety issues were the top priority on this particular file. When I suggest there was only one such incident, I'm quoting the RCMP. It is our law enforcement authorities themselves who have indicated that we don't have that other information. And while I would agree with you that there is the prospect or at least the possibility that other people may have been harmed, we should put this in context as well. According to some research I was doing based on Canadian Medical Association data, more than 10,000 Canadians a year die due to bad drug interactions when the drugs they've been prescribed are not the right ones interacting with other drugs. So that's obviously an enormous problem as well.
But the point is that, yes, it's possible other people are being affected, and this issue—the health and safety issue—ought to be, from my perspective, the top priority on the counterfeit file. But in the broader scheme of the consequences of pharmaceutical use, at least for the moment, the data we do have suggest it's a relatively minor problem.